“The evidence would suggest that perhaps we need to investigate this pathway and perhaps this drug in both Parkinson’s, ...
Nilotinib (Tasigna) — a drug for myeloid leukemia — improved biomarkers and cognitive outcomes in study participants with dementia with Lewy bodies, a new study finds.
Medpage Today on MSN14d
Leukemia Drug Shows Promise in Dementia With Lewy Bodies"We're looking at repositioning or repurposing tyrosine kinase inhibitors for neurodegenerative diseases, including Lewy body ...
ComingSoon on MSN16d
The Penguin: What is Lewy Body Dementia? Francis Cobb’s Diagnosis ExplainedThe Penguin recently aired its sixth episode. The episode was filled with interesting twists and turns, leaving viewers on ...
Patient characteristics are consistent with other DLB studies -PURCHASE, N.Y., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, ...
Lewy body dementia (LBD) is a progressive neurodegenerative disease that shares traits with both Parkinson's disease and Alzheimer's disease but can be more difficult to diagnose. Symptoms can ...
One in 11 people over the age of 65 have dementia in the UK, with a devastating impact on sufferers and their families, and ...
Other causes may include vascular dementia, Lewy body dementia, brain injuries, and certain underlying health conditions. Major neurocognitive disorder, also known as dementia, is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback